WallStSmart

Aramark Holdings (ARMK)vsLichen China Limited Class A Ordinary Shares (LICN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Aramark Holdings generates 80842% more annual revenue ($19.85B vs $24.52M). ARMK leads profitability with a 1.9% profit margin vs -89.6%. ARMK earns a higher WallStSmart Score of 64/100 (C+).

ARMK

Buy

64

out of 100

Grade: C+

Growth: 8.0Profit: 5.0Value: 4.7Quality: 5.0
Piotroski: 4/9Altman Z: 1.82

LICN

Avoid

29

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.0Quality: 8.5
Piotroski: 2/9Altman Z: 9.00
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ARMKSignificantly Overvalued (-44.8%)

Margin of Safety

-44.8%

Fair Value

$39.30

Current Price

$58.55

$19.25 premium

UndervaluedFair: $39.30Overvalued

Intrinsic value data unavailable for LICN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ARMK2 strengths · Avg: 8.0/10
PEG RatioValuation
0.888/10

Growing faster than its price suggests

EPS GrowthGrowth
33.3%8/10

Earnings expanding 33.3% YoY

LICN3 strengths · Avg: 10.0/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
9.0010/10

Safe zone — low bankruptcy risk

Areas to Watch

ARMK4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.824/10

Grey zone — moderate risk

Profit MarginProfitability
1.9%3/10

1.9% margin — thin

Operating MarginProfitability
4.4%3/10

Operating margin of 4.4%

Debt/EquityHealth
1.913/10

Elevated debt levels

LICN4 concerns · Avg: 2.5/10
Market CapQuality
$18.90M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-39.8%2/10

ROE of -39.8% — below average capital efficiency

Revenue GrowthGrowth
-56.1%2/10

Revenue declined 56.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : ARMK

The strongest argument for ARMK centers on PEG Ratio, EPS Growth. PEG of 0.88 suggests the stock is reasonably priced for its growth.

Bull Case : LICN

The strongest argument for LICN centers on Price/Book, Debt/Equity, Altman Z-Score.

Bear Case : ARMK

The primary concerns for ARMK are Altman Z-Score, Profit Margin, Operating Margin. A P/E of 40.3x leaves little room for execution misses. Debt-to-equity of 1.91 is elevated, increasing financial risk.

Bear Case : LICN

The primary concerns for LICN are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

ARMK profiles as a value stock while LICN is a turnaround play — different risk/reward profiles.

ARMK carries more volatility with a beta of 1.19 — expect wider price swings.

ARMK is growing revenue faster at 9.3% — sustainability is the question.

ARMK generates stronger free cash flow (17M), providing more financial flexibility.

Bottom Line

ARMK scores higher overall (64/100 vs 29/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aramark Holdings

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Aramark provides uniform food, facilities, and services to education, health, business and industrial, sports, recreation, and correctional clients in the United States and internationally. The company is headquartered in Philadelphia, Pennsylvania.

Visit Website →

Lichen China Limited Class A Ordinary Shares

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Lichen China Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company is headquartered in Jinjiang, China.

Want to dig deeper into these stocks?